Arrowhead Pharmaceuticals Stock Falls After Early-Stage Data From RNA-Based Therapeutic For Kidney Diseases
Arrowhead's ARO-C3 cut C3 levels by up to 89% and proteinuria by 41% in a Phase 1/2 trial. Additional results will be ...
Sporting News2h
Lakers may acquire $32 million ex-Cavs scorer to complement LeBron James via summer signing
In their first full contest without four-time NBA champion LeBron James in the lineup due to a groin injury, the Lakers' star duo of Luka Dončić and Austin Reaves scored a combined 39 points while ...